Tag Archives: CBAN

Top 5 Blue Chip Stocks For 2023

No matter how many warnings experts issue regarding penny stocks, people invariably find their way into this speculative arena. And that issue has become even more prominent thanks to mobile trading apps like Robinhood (NASDAQ:HOOD). With the ability to wager on the full spectrum of investment vehicles right at your fingertips, Robinhood is somewhat of a mixed bag.

On the one hand, let’s at least give credit where it’s due. Prior to the novel coronavirus pandemic, financial analysts bemoaned that younger people were investing at a lower rate than prior generations at their....More>>>

Top 10 Financial Stocks For 2023

Workday shares are trading higher late Thursday after the cloud-based provider of enterprise HR and financial software posted better-than-expected results for its fiscal second quarter ended July 31. 

For the quarter, Workday (ticker: WDAY) reported revenue of $1.26 billion, up 19% from a year ago, and slightly ahead of the Street consensus estimate of $1.24 billion. Subscription revenue was $1.11 billion, up 20%, and ahead of the company’s guidance range of $1.095 billion to $1.097 billion. Non-GAAP profits were $1.23 a share, well ahead of consensus at 78 cents. Under generally....More>>>

Top 10 Financial Stocks To Invest In 2023

Robinhood Markets (NASDAQ:HOOD) is helping a new generation of young investors get started building wealth, but the “gamification” of its app could pose problems. Instead of Robinhood, Motley Fool contributors Jason Hall, Toby Bordelon, and Nicholas Rossolillo discuss three other fintech stocks they like on this Motley Fool Live “The 5” segment recorded on Sept. 15.

Jason Hall: Toby dropped this one in here. This is all over the financial media today, Robinhood’s College Tour. The company is launching a marketing campaign, targeting college students, and....More>>>

Best Financial Stocks To Invest In Right Now

James “Rev Shark” Deporre isn’t one to let grass grow under his feet.

With the stock market on a downward trend, Deporre has his sights set on more than a dozen stocks on his “shopping list” that should survive the test of time (and of a choppy market) and add some heft to an investor’s portfolio.

“The bearish narrative has been gaining some traction and virtually everyone is aware of the fact that September is on average the weakest month of the year,” Deporre wrote recently on Real Money. “The combination of extended technical conditions, with some slowing....More>>>

Top 5 Financial Stocks To Watch For 2023

HC Wainwright reaffirmed their buy rating on shares of Werewolf Therapeutics (NASDAQ:HOWL) in a research report report published on Tuesday morning, PriceTargets.com reports. HC Wainwright currently has a $32.00 price target on the stock.

Several other analysts have also recently commented on the stock. Jefferies Financial Group began coverage on shares of Werewolf Therapeutics in a report on Tuesday, May 25th. They set a buy rating and a $22.00 price target for the company. Bank of America began coverage on shares of Werewolf Therapeutics in a report on Friday, September 10th. They....More>>>